Abstract
Nonsteroidal mineralocorticoid receptor antagonists (MRAs) present a promising therapeutic option in cardiorenal diseases, mitigating the limitations ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
